Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 141, Issue 11, Pages 2348-2358
Publisher
Wiley
Online
2017-08-12
DOI
10.1002/ijc.30929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of CD44 in glioblastoma multiforme
- (2016) Kelly L. Mooney et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence
- (2016) Matthew D. Wood et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
- (2016) Alba A. Brandes et al. NEURO-ONCOLOGY
- A comprehensive profile of recurrent glioblastoma
- (2016) B Campos et al. ONCOGENE
- Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression
- (2015) Andre Wendindonde Nana et al. Asian Pacific Journal of Cancer Prevention
- TGF Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response
- (2015) J. Han et al. CANCER RESEARCH
- Transforming growth factor β and bone morphogenetic protein actions in brain tumors
- (2015) Laia Caja et al. FEBS LETTERS
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment
- (2015) Fares Nigim et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
- (2015) Carolina S Ilkow et al. NATURE MEDICINE
- Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
- (2015) Wei Zhang et al. NEOPLASIA
- Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas
- (2014) H. Wakimoto et al. CLINICAL CANCER RESEARCH
- Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
- (2014) Jianfang Ning et al. Frontiers in Microbiology
- EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
- (2013) Krishna M. Talasila et al. ACTA NEUROPATHOLOGICA
- Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
- (2012) U.D. Kahlert et al. CANCER LETTERS
- Regulation of EMT by TGFβ in cancer
- (2012) Carl-Henrik Heldin et al. FEBS LETTERS
- Prospective, high-throughput molecular profiling of human gliomas
- (2012) Andrew S. Chi et al. JOURNAL OF NEURO-ONCOLOGY
- Multimechanistic Tumor Targeted Oncolytic Virus Overcomes Resistance in Brain Tumors
- (2012) Kaoru Tamura et al. MOLECULAR THERAPY
- Standards of care for treatment of recurrent glioblastoma—are we there yet?
- (2012) Michael Weller et al. NEURO-ONCOLOGY
- Oncolytic Herpes Simplex Virus Counteracts the Hypoxia-Induced Modulation of Glioblastoma Stem-Like Cells
- (2012) Donatella Sgubin et al. Stem Cells Translational Medicine
- Blockade of TGF- Signaling by the TGF R-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
- (2011) M. Zhang et al. CANCER RESEARCH
- Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts
- (2011) T. A. Cheema et al. CLINICAL CANCER RESEARCH
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
- (2011) R. Kanai et al. CLINICAL CANCER RESEARCH
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma
- (2011) Wei Zhang et al. MOLECULAR THERAPY
- Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
- (2011) H. Wakimoto et al. NEURO-ONCOLOGY
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
- (2010) Masayuki Nitta et al. PLoS One
- TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
- (2009) Silvia Peñuelas et al. CANCER CELL
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Epithelial-mesenchymal transition in cancer development and its clinical significance
- (2009) Masaaki Iwatsuki et al. CANCER SCIENCE
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
- (2009) Hiroaki Ikushima et al. Cell Stem Cell
- Mechanisms of the epithelial–mesenchymal transition by TGF-β
- (2009) Michael K Wendt et al. Future Oncology
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
- (2008) T. Martens et al. CLINICAL CANCER RESEARCH
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started